Cargando…

IL-32 is induced by activation of toll-like receptors in multiple myeloma cells

Multiple myeloma (MM) is a hematological cancer characterized by accumulation of malignant plasma cells in the bone marrow. The patients are immune suppressed and suffer from recurrent and chronic infections. Interleukin-32 is a non-conventional, pro-inflammatory cytokine expressed in a subgroup of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aass, Kristin Roseth, Tryggestad, Synne Stokke, Mjelle, Robin, Kastnes, Martin H., Nedal, Tonje Marie Vikene, Misund, Kristine, Standal, Therese
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978100/ https://www.ncbi.nlm.nih.gov/pubmed/36875074 http://dx.doi.org/10.3389/fimmu.2023.1107844

Ejemplares similares

Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
por: Aass, Kristin Roseth, et al.
Publicado: (2022)

Comprehensive small RNA-sequencing of primary myeloma cells identifies miR-105-5p as a predictor of patient survival
por: Roseth Aass, Kristin, et al.
Publicado: (2022)

Intracellular IL-32 regulates mitochondrial metabolism, proliferation, and differentiation of malignant plasma cells
por: Aass, Kristin Roseth, et al.
Publicado: (2021)

The pro-tumorigenic cytokine IL-32 has a high turnover in multiple myeloma cells due to proteolysis regulated by oxygen-sensing cysteine dioxygenase and deubiquitinating enzymes
por: Kastnes, Martin, et al.
Publicado: (2023)

Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
por: Sponaas, Anne Marit, et al.
Publicado: (2021)

sMETASeq: Combined Profiling of Microbiota and Host Small RNAs
por: Mjelle, Robin, et al.
Publicado: (2020)

Automated Quantification of Human Osteoclasts Using Object Detection
por: Kohtala, Sampsa, et al.
Publicado: (2022)

Monitoring multiple myeloma by quantification of recurrent mutations in serum
por: Rustad, Even Holth, et al.
Publicado: (2017)

Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade
por: Yang, Rui, et al.
Publicado: (2020)

Comparison of the Seven Interleukin-32 Isoforms’ Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity
por: Shim, Saerok, et al.
Publicado: (2022)

Decoys and Regulatory “Receptors” of the IL-1/Toll-Like Receptor Superfamily
por: Garlanda, Cecilia, et al.
Publicado: (2013)

IL-32 as a potential biomarker and therapeutic target in skin inflammation
por: Wallimann, Alexandra, et al.
Publicado: (2023)

Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium
por: Gopalakrishnan, Shreya, et al.
Publicado: (2022)

The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells
por: Slørdahl, Tobias S., et al.
Publicado: (2016)

The Toll for Trafficking: Toll-Like Receptor 7 Delivery to the Endosome
por: Petes, Carlene, et al.
Publicado: (2017)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

A Role for Syntaxin 3 in the Secretion of IL-6 from Dendritic Cells Following Activation of Toll-Like Receptors
por: Collins, Laura E., et al.
Publicado: (2015)

Cytotoxic Effect on Human Myeloma Cells and Leukemic Cells by the Agaricus blazei Murill Based Mushroom Extract, Andosan™
por: Tangen, Jon-Magnus, et al.
Publicado: (2017)

Bone morphogenetic protein-9 suppresses growth of myeloma cells by signaling through ALK2 but is inhibited by endoglin
por: Olsen, O E, et al.
Publicado: (2014)

Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis
por: El-Far, Mohamed, et al.
Publicado: (2021)

TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan
por: Håland, Erling, et al.
Publicado: (2021)

Finding a Toll on the Route: The Fate of Osteoclast Progenitors After Toll-Like Receptor Activation
por: Souza, Pedro P. C., et al.
Publicado: (2019)

The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM
por: Follin-Arbelet, Virginie, et al.
Publicado: (2015)

Naltrexone Inhibits IL-6 and TNFα Production in Human Immune Cell Subsets following Stimulation with Ligands for Intracellular Toll-Like Receptors
por: Cant, Rachel, et al.
Publicado: (2017)

Activation of Toll-Like Receptors Differentially Modulates Inflammation in the Human Reproductive Tract: Preliminary Findings
por: Benjelloun, Fahd, et al.
Publicado: (2020)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

The serine protease matriptase inhibits migration and proliferation in multiple myeloma cells
por: Steiro, Ida, et al.
Publicado: (2022)

Hydroxychloroquine potentiates carfilzomib toxicity towards myeloma cells
por: Baranowska, Katarzyna, et al.
Publicado: (2016)

Toll-Like Receptors of Deuterostome Invertebrates
por: Satake, Honoo, et al.
Publicado: (2012)

Toll-Like Receptors and Skin Cancer
por: Burns, Erin M., et al.
Publicado: (2014)

Toll-Like Receptors and Prostate Cancer
por: Zhao, Shu, et al.
Publicado: (2014)

Toll-Like Receptor Signaling Pathways
por: Kawasaki, Takumi, et al.
Publicado: (2014)

Toll-Like Receptors in Esophageal Cancer
por: Kauppila, Joonas H., et al.
Publicado: (2014)

Ulvan Activates Chicken Heterophils and Monocytes Through Toll-Like Receptor 2 and Toll-Like Receptor 4
por: Guriec, Nathalie, et al.
Publicado: (2018)

Correction: MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2018)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma
por: Duan, Deming, et al.
Publicado: (2021)

Toll-Like Receptor 9 in Breast Cancer
por: Sandholm, Jouko, et al.
Publicado: (2014)

The Role of Toll-Like Receptors in Hematopoietic Malignancies
por: Monlish, Darlene A., et al.
Publicado: (2016)

Toll-like Receptors and Inflammatory Bowel Disease
por: Lu, Yue, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3v6nhe67voe87c730otn74pmam